Learn how GLP-1 receptor agonists like semaglutide and tirzepatide work for weight loss, who qualifies, and what to expect from treatment.
GLP-1 receptor agonists have transformed the weight loss landscape. Originally developed for type 2 diabetes, medications like semaglutide and tirzepatide are now FDA-approved for chronic weight management — and the results are remarkable.
GLP-1 (glucagon-like peptide-1) is a hormone your body naturally produces after eating. It signals your brain to feel full, slows gastric emptying, and helps regulate blood sugar.
GLP-1 receptor agonists mimic this hormone at much higher levels than your body produces naturally. The result: significantly reduced appetite, fewer cravings, and meaningful weight loss.
When you inject a GLP-1 medication, it binds to receptors in your brain's hypothalamus — the control center for hunger and satiety. This isn't willpower. It's biochemistry working in your favor.
Patients consistently report that food simply becomes less of a preoccupation. The constant mental chatter about what to eat next quiets down.
Both medications are GLP-1 receptor agonists, but they work slightly differently:
Semaglutide (the active ingredient in Ozempic and Wegovy) targets the GLP-1 receptor alone. Clinical trials showed an average weight loss of 15% of body weight over 68 weeks.
Tirzepatide (the active ingredient in Mounjaro and Zepbound) targets both GLP-1 and GIP receptors. This dual action led to even greater results in trials — up to 22.5% body weight reduction.
Both medications are administered as once-weekly subcutaneous injections. Most patients start on a low dose and gradually increase over several months.
The FDA-approved criteria for GLP-1 weight loss medications include:
Your healthcare provider will also consider your medical history, current medications, and overall health before prescribing.
Most patients begin on the lowest dose. Side effects — primarily nausea and reduced appetite — tend to be mild and improve as your body adjusts.
As your dose gradually increases, weight loss accelerates. Most patients see their most significant results during this period. The key is consistency with weekly injections and following your provider's guidance.
GLP-1 medications work best as part of a comprehensive approach that includes balanced nutrition and regular physical activity. Your provider will help you find the right maintenance dose.
Brand-name GLP-1 medications can cost over $1,000 per month without insurance. However, compounded versions offer the same active ingredients at a fraction of the cost.
At Weight Method, treatment starts at $279/month for compounded semaglutide or tirzepatide, including provider consultations and medication delivery.
Yes, when prescribed and monitored by a licensed healthcare provider. Both semaglutide and tirzepatide have undergone extensive clinical trials involving thousands of participants.
Most patients notice reduced appetite within the first 1-2 weeks. Measurable weight loss typically begins within the first month, with the most significant results at 3-6 months.
You don't need to follow a strict diet, but the best results come from combining medication with balanced eating habits and regular activity. The medication makes it much easier to eat less and make healthier choices.
Take our 2-minute quiz to see if you qualify for GLP-1 treatment.
Start QuizFree consultation. No commitment.